Lixte Biotechnology Holdings Announces New Appointment to Board of Directors

ohn S. Kovach, M.D., Chair, Board of Directors and CEO of Lixte Biotechnology Holdings, Inc. announces the appointment of Mel Sorensen, M.D. to the company’s Board of Directors. Dr. Sorensen is currently Board Director, President and Chief Executive Officer of Ascenta Therapeutics. He is a highly experienced leader and administrator in cancer therapeutics and cancer drug development. Trained... 

Tags: Ascenta Therapeutics, Bayer, biomarker technology, biopharmaceuticals, biotechnology, brain cancer, brain tumor, brain tumors, cancer, cancer therapeutics, cancer therapy, cancers, China, DC, Drug Development, drug discovery, Florida, GlaxoSmithKline, glioblastoma multiforme, Investment, large pharmaceutical, leukemias, liver cancer, Lixte Biotechnology Holdings Inc., Management Change, Mayo Clinic, medulloblastoma, Mel Sorensen, Minnesota

Paratek Pharmaceuticals, Inc. announced an annual Interscience Conference on Antimicrobial Agents and Chemotherapy

Paratek Pharmaceuticals, Inc. today announced the Company’s lead product, amadacycline, formerly PTK 0796, a first-in-class aminomethylcycline, will be the subject of a Late Breaker poster presentation at the 48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). ICAAC will be held in Washington, D.C. from October 25 – October 28, 2008. More information on the poster... 

Tags: acne, active chemical synthesis effort, antibiotics, bacterial infections, Boston, chemotherapy, cystic fibrosis, DC, FSMA, Massachusetts, Merck & Co., MerckSerono, multiple sclerosis, muscular dystrophy, neurodegenerative diseases, Paratek Pharmaceuticals Inc., rosacea, spinal muscular atrophy, Warner-Chilcott, Washington

Boston Scientific Inc. announced comprehensive data from the TAXUS ATLAS clinical program

Boston Scientific Corporation today announced comprehensive data from the TAXUS ATLAS clinical program, a series of global, prospective, multi-center, single-arm, historically controlled trials, which evaluate the TAXUS® Liberte® Paclitaxel-Eluting Stent System in a variety of lesions and patient groups. The TAXUS Liberte Stent received U.S. Food and Drug Administration approval on Friday. Results... 

Tags: Auckland, Boston Scientific Corporation, Cardiovascular Research Foundation, Center for Cardiac and Vascular Research, DC, Europe, federal law, John A. Ormiston, Mark A. Turco, Mercy Hospital, Michigan, myocardial infarction, New Zealand, patient groups, Securities and Exchange Commission, thrombosis, US Food and Drug Administration, Washington, Washington Adventist Hospital

Similarly Low Rates in Patients With Diabetes Compared to Non-Diabetics

Boston Scientific Corporation (NYSE: BSX – News) today announced results from an analysis of nearly 7,500 patients from its TAXUS ARRIVE 1 and 2 registries, which are designed to confirm the performance of the TAXUS® Express2(TM) Paclitaxel-Eluting Coronary Stent System in real-world practice. The two-year pooled ARRIVE data showed that the TAXUS Stent reduced clinical restenosis in patients... 

Tags: angioplasty, Boston Scientific Corporation, cardiac disease, cardiogenic shock, Cardiovascular Research Foundation, congestive heart failure, DC, diabetes, Donald S. Baim, John M. Lasala, myocardial infarction, renal disease, Securities and Exchange Commission, St. Louis, thrombosis, thrombus, Washington, Washington University School of Medicine

CorMatrix Cardiovascular, Inc presented Data on Its Next Generation ECM Technology at Annual Transcatheter Cardiovascular Therapeutics Conference

CorMatrix Cardiovascular, Inc., an Atlanta-based company dedicated to developing and delivering unique extracellular matrix (ECM(TM)) biomaterial devices that harness the body’s innate ability to repair damaged cardiovascular tissue, today announced that Robert G. Matheny, M.D., Chief Scientific Officer, will present data on the company’s next generation ECM Technology(TM) at the annual... 

Tags: Acellular Matrix Emulsion, Atlanta, Beecher Lewis, biomaterial devices, cardiovascular applications, Cell Therapy, CorMatrix Cardiovascular Inc., DC, ECM Technology, generation ECM Technology, generation product, Georgia, heart failure, Purdue University, Robert G. Matheny, treatment for heart failure, Washington

XTENT, Inc. announced to present long-term follow-up data from the CUSTOM I, II and III clinical trials

XTENT, Inc. today announced that it plans to present long-term follow-up data from the CUSTOM I, II and III clinical trials next week at the Cardiovascular Research Foundation’s twentieth annual Transcatheter Cardiovascular Therapeutics meeting in Washington, DC. The CUSTOM clinical trials are prospective studies designed to investigate the safety and efficacy of the Custom NX® drug eluting... 

Tags: CAD, cardiovascular disease, Cardiovascular Research Foundation, coronary artery disease, DC, DES Systems, Europe, Pieter R. Stella, Securities and Exchange Commission, The Netherlands, treatment of coronary artery disease, Washington, XTENT Inc.

Infohrm Releases New Case Study on Greater Baltimore Medical Center’s Workforce Planning Initiative

Infohrm, the global leader in workforce planning, reporting and analytics solutions, today released a case study highlighting the success of the Greater Baltimore Medical Center (GBMC) in implementing a new workforce planning process that will save the organization over $4 million in staffing costs. As with many healthcare providers, GBMC, a 335-bed community hospital with 3,200 staff (the organization... 

Tags: analytics solutions, Baltimore County, Brian Kelly, capital analytics solutions, DC, GBMC, GBMC Foundation, Greater Baltimore Medical Center, healthcare providers, Human Capital Management Software, Infohrm, Infohrm North America, John Boudreau, Mark Thomas, Pennsylvania, Peter Cappelli, professional development services, the University of Pennsylvania, Washington

Mental Health America Hosts “Inaugural Mental Health Promotion and Prevention Summit”

This June 6-7 in Washington, D.C., Mental Health America will convene an extraordinary group of mental health experts, advocates, organizations and researchers committed to advancing a promotion and prevention agenda to drive down the tragically high rates and profound impact of mental health and substance use conditions in the United States. The two-day event, entitled the “Inaugural Mental... 

Tags: America, Australia, Carl C. Bell, Center for Psychiatric Research at Maine Medical C, Center for Psychiatric Research, Children, DC, Drug Abuse, genomics, Gregor Henderson, Harvard Medical School, Helen Herrman, Institute of Medicine, Institute of Medicine Report, IOM committee, Kevin Haggerty, Leslie Leve, Maine Medical Center, Melbourne, neuroscience, Nora D. Volkow, Oregon, Prevention of Mental Disorders, Schizophrenia, Scottish Government, Seattle, Social Learning Center, Susan Dentzer, Thomas Insel

Mrs. Kennedy became assistant chief of nursing services at the VA Hospita

Born Rose Catherine Schamine in Rochester, she graduated from the E.J. Meyer Memorial Hospital School of Nursing in 1941, referred to as the Pearl Harbor Class. She earned a bachelor’s degree in nursing in 1949 from the University of Buffalo and a master’s degree in nursing administration in 1961, also from UB. Her nursing career spanned 25 years at VA hospitals across the country, beginning... 

Tags: 44th General Hospital, Army, Buffalo, Buffalo's VA Hospital, California, Catholic Church, Christian Burial, DC, E.J. Meyer Memorial Hospital School of Nursing, Francis J. Kennedy, Massachusetts, National Active and Retired Federal Employees Associati, Oakland, Overseas Service League, Rochester, Rose Catherine Schamine, St. Joseph, St. Louis, St. Louis Church, the Philippines, UB's School of Nursing Alumni, University of Buffalo, VA hospital, Washington, Women's Overseas Service League

School of Nursing Dedicates New Nursing Education Building

Several hundred people filled the patio and spilled down the steps outside McLeod Hall Friday morning to celebrate the dedication of the University of Virginia School of Nursing’s new Claude Moore Nursing Education Building. Even the weather seemed to be in the spirit of the occasion, offering glorious skies and no hint of the forecasted arrival of Tropical Storm Hanna. The event had the atmosphere... 

Tags: Bowie Gridley Architects, California, Center for Nursing Historical Inquiry, Center for the Study of Complementary and Alternative T, Claude Moore, Claude Moore Charitable Foundation, Claude Moore Nursing, Claude Moore Professorship, Clinical Simulation Learning Center, DC, Dean Dorrie Fontaine, Dirtworks, Education Building, Health Foundation, Investment, James C. Roberts, Jeanette Lancaster, John T. Casteen III, Leigh B. Middleditch Jr., Martin Horn Inc., McLeod Hall, Medical School, Nursing Advisory Board, Nursing School, Rural Health Care Research Center, San Francisco, School of Medicine, self-care, SIMULATION

lixte biotechnology, nurses job in dhahran, nursing jobs vacancies in abu dhabi, nursing vacancey for moh kuwait after june 2009, duties and responsibilities of rural health nurse in the philippines, rn job in china shanghai, duties and responsibilities of chief nurse in the philippines, duties and responsibilities of a director of nursing in the